
																
																	A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal Cancer
																
																
																
															Keywords: Advanced CRC; IXO regimen; Metastatic colorectal cancer; Phase 1; Triple combination;